Cargando…
High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma
Background: Primary adenosquamous carcinoma (ASC) is a rare malignant tumor in the lung and its biological behavior has not yet been thoroughly described. In this study, we aimed to explore the clinical and biological role of CXCR4 in patients with resected lung ASC. Methods: We retrospectively revi...
Autores principales: | Zhu, Qiaoliang, Luo, Rongkui, Gu, Jie, Hou, Yingyong, Chen, Zongwei, Xu, Fengkai, Wang, Lin, Mao, Wei, Lu, Chunlai, Ge, Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959020/ https://www.ncbi.nlm.nih.gov/pubmed/31949484 http://dx.doi.org/10.7150/jca.36498 |
Ejemplares similares
-
A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies
por: Li, Yin, et al.
Publicado: (2019) -
Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data
por: Li, Yin, et al.
Publicado: (2018) -
Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study
por: Zhao, Guangyin, et al.
Publicado: (2023) -
Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway
por: Xu, Fengkai, et al.
Publicado: (2019) -
Up-regulation Of EIF3e Is Associated with The Progression of Esophageal Squamous Cell Carcinoma and Poor Prognosis in Patients
por: Xu, Fengkai, et al.
Publicado: (2018)